TREM2 and colorectal carcinoma: Using HT29 CRC cells, Kim and colleagues demonstrated that antibody-mediated TREM2 neutralization resulted in increased cell proliferation, induction of the S phase of the cell cycle, increased cell migration, and increased invasive capacity.